Email ID
Password
Scrip   
Rabeprazole resubmitted for GORD in Japan
01 October 2009
Ian Haydock

Eisai has resubmitted an approval filing in Japan for its proton pump inhibitor Pariet (rabeprazole), for the additional indication of non-erosive gastro-oesophageal reflux disease (GORD/GERD).

The submission was originally made in March 2006 but was withdrawn in February 2008 following...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36